Clinical Development, Computational Chemistry and Marketing

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

JULY 31, 2023

This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

Computational Chemistry

Computational Chemistry Science Clinical Trials Pharmaceutical Companies

The Book of Nimbus

LifeSciVC

APRIL 27, 2023

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.

Small Molecule

Small Molecule Computational Chemistry Engineering Clinical Development

Drug Discovery Digest

Sygnature Discovery accelerates global growth with major North American acquisition

The Book of Nimbus

Webinars

Stay Connected